Pretreatment With Intracoronary Enalaprilat Protects Human Myocardium During Percutaneous Coronary Angioplasty
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The effect of an angiotensin-converting enzyme inhibitor and a K+ATP channel opener on warm up anginaEuropean Heart Journal, 2004
- Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humansJACC, 2003
- Nitroglycerin and Delayed Preconditioning in HumansCirculation, 2001
- Bradykinin-induced preconditioning in patients undergoing coronary angioplastyJACC, 1999
- Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial InfarctionCirculation, 1998
- Angiotensin-Converting Enzyme Inhibitors Potentiate Preconditioning Through Bradykinin B2Receptor Activation in Human HeartJACC, 1997
- Role of Kinins in the Pathophysiology of Myocardial Ischemia: In Vitro and In Vivo StudiesDiabetes, 1996
- Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonistEuropean Journal of Pharmacology, 1990
- Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarctionAmerican Heart Journal, 1985
- Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.Circulation, 1982